General Information of Drug (ID: DM5P72L)

Drug Name
HB-202
Indication
Disease Entry ICD 11 Status REF
Squamous cell carcinoma 2B60-2D01 Phase 1/2 [1]
Cross-matching ID
TTD ID
DILZ67

References

1 ClinicalTrials.gov (NCT04180215) A Study of TheraT Vector(s) Expressing HPV 16+ in Patients With HPV 16+ Confirmed Cancers. U.S. National Institutes of Health.